Intelligent Bio Solutions Inc.

Equities

INBS

US36151G6008

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 01:54:27 2024-04-19 pm EDT 5-day change 1st Jan Change
2.71 USD +1.12% Intraday chart for Intelligent Bio Solutions Inc. -20.00% -33.91%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Intelligent Bio Solutions Inc. announced that it has received $10.116165 million in funding CI
Intelligent Bio Solutions Inc. announced that it expects to receive $10.116165 million in funding CI
Top Premarket Decliners MT
Top Midday Gainers MT
Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q2 Revenue $764,063 MT
Intelligent Bio Solutions Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Sector Update: Health Care Stocks Advance Late Afternoon MT
Sector Update: Health Care Stocks Decline Friday Afternoon MT
Top Midday Gainers MT
Intelligent Bio Solutions Inc. Provides Unaudited Preliminary Earnings Guidance for the Second Quarter and Six Months Ended December 31, 2023 CI
Sector Update: Health Care Stocks Stronger Late Afternoon MT
Sector Update: Health Care MT
Intelligent Bio Solutions Says Fingerprinting Drug Screening System Being Used by UK Timber Processor; Shares Soar MT
James Jones & Sons Ltd. Adopts Intelligent Bio Solutions Inc.'s Fingerprint Drug Screening System Across its 25 Sites and 1,300 Employees CI
Intelligent Bio Solutions Inc. Announces Selection of the Revolutionary Portable Intelligent Fingerprinting Drug Screening System by Dgp plc CI
Intelligent Bio Solutions Receives NATA Accreditation for Its Revolutionary Fingerprint Sweat Drug Screening System CI
P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring Staff CI
Intelligent Bio Solutions Inc. Announces Titan Cranes and Rigging Pty Ltd. Adopts Intelligent Fingerprinting Drug Screening System CI
Intelligent Bio Solutions to Provide Fingerprinting Drug Screening System to Australian Firm; Shares Rise MT
Wall Street Set to Open Slightly Higher as Investors Parse Powell Remarks MT
Top Premarket Gainers MT
Sector Update: Health Care Stocks Falling Late Afternoon MT
Top Midday Gainers MT
Wall Street Set to Open Higher Thursday as Jobless Claims Fall, Ahead of Powell Speech MT
Fed's Chief's Upcoming Policy Markets Marginally Lift Exchange-Traded Funds, Equity Futures Pre-Bell Thursday MT
Chart Intelligent Bio Solutions Inc.
More charts
Intelligent Bio Solutions Inc. is a life sciences company. The Company is engaged in developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It operates through two segments, namely Commercially available Intelligent Fingerprinting Products (IFPG) and Development Stage Saliva Glucose Biosensor Platform (SGBP). Its product portfolio includes a portable drug screening system that works by analyzing fingerprint sweat using a one-time cartridge and portable handheld reader and also includes a development stage range of biosensor- based Point of Care diagnostic tests (POCT) that are developed in the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology. Its product candidate is the Saliva Glucose Biosensor (SGB), a POCT expected to substitute the finger pricking invasive blood glucose monitoring for diabetic patients. Its Biosensor Platform helps to detect multiple biological analytes.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.8 USD
Average target price
42 USD
Spread / Average Target
+1,400.00%
Consensus
  1. Stock Market
  2. Equities
  3. INBS Stock
  4. News Intelligent Bio Solutions Inc.
  5. Sector Update: Healthcare Stocks Edging Higher in Late Trade